ResMed(FRA) RMEA

Market Cap€28.13B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€20.00

+1.52%

+0.30Today

ResMed Financials at a Glance

Market Cap

€28.13B

Revenue (TTM)

€4.85K

Net Income (TTM)

€1.31K

EPS (TTM)

€0.89

P/E Ratio

21.79

Dividend

€0.21

Beta (Volatility)

0.05 (Low)

Dividend

€0.21

Beta (Volatility)

0.05 (Low)

Price

€20.00

Volume

Open

€20.00

Price

€20.00

Volume

Open

€20.00

Previous Close

€20.00

Daily Range

€20.00 - €20.00

52-Week Range

€15.30 - €24.00

Estimated Earnings Date

N/A

Dividend

€0.21

Beta (Volatility)

0.05 (Low)

Price

€20.00

Volume

Open

€20.00

Previous Close

€20.00

Daily Range

€20.00 - €20.00

52-Week Range

€15.30 - €24.00

Estimated Earnings Date

N/A

RMEA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ResMed

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,370

CEO

Mick Farrell, MBA

Website

www.resmed.com

RMEA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

24.09%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.59%

Dividend Yield

1.08%

Payout Ratio

N/A

Stock Overview

Market Cap

€28.13B

Shares Outstanding

1.44B

Volume

Avg. Volume

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

ResMed Performance Analysis

ResMed annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-06-30	EUR 4,038,940,836	27.1%
2024	2024-06-30	EUR 4,332,821,088	7.3%
2025	2025-06-30	EUR 4,733,350,898	9.2%
2026	2026-06-30	EUR 4,846,919,898	2.4%

ResMed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-06-30	EUR 0.58	23.7%
2024	2024-06-30	EUR 0.64	9.9%
2025	2025-06-30	EUR 0.87	36.6%
2026	2026-06-30	EUR 0.89	2.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€1.26K

+1.1%

Gross Profit

€731.67

+1.0%

Gross Margin

58.12%

+1.0%

Market Cap

€28.13B

N/A

Market Cap/Employee

€2.16

N/A

Employees

11,370

N/A

Net Income

€329.77

+1.0%

EBITDA

€438.42

+0.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€2.01K

+14.3%

Total Debt

€722.40

+1.0%

Accounts Receivable

€948.97

+1.1%

Inventory

€827.26

+1.0%

Long Term Debt

€469.54

+0.7%

Short Term Debt

€252.86

+7.3%

Return on Assets

17.64%

+0.9%

Return on Invested Capital

17.31%

+1.1%

Free Cash Flow

€370.21

+0.9%

Operating Cash Flow

€416.78

+1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About RMEA

What is the current price of ResMed?

ResMed is trading at €20.00 per share.

What is the 52-week range for ResMed?

Over the past 52 weeks, ResMed has traded between €15.30 and €24.00.

How much debt does ResMed have?

As of the most recent reporting period, ResMed reported total debt of €722.40M.

How much cash does ResMed have on hand?

ResMed reported €1.29B in cash and cash equivalents in its most recent financial results.

What is ResMed’s dividend yield?

ResMed currently has a dividend yield of 1.08%.

ResMed(FRA) RMEA

ResMed Financials at a Glance

RMEA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ResMed

RMEA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ResMed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RMEA

What is the current price of ResMed?

What is the 52-week range for ResMed?

How much debt does ResMed have?

How much cash does ResMed have on hand?

What is ResMed’s dividend yield?

Premium Investing Services